{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:42:48Z","timestamp":1792784568008,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"The Porphyrias Consortium","award":["U54DK083909"],"award-info":[{"award-number":["U54DK083909"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K23DK095946"],"award-info":[{"award-number":["K23DK095946"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ymgme.2019.01.020","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T02:28:53Z","timestamp":1548556133000},"page":"298-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Erythropoietic Protoporphyria and X-Linked Protoporphyria: pathophysiology, genetics, clinical manifestations, and management"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8047-5011","authenticated-orcid":false,"given":"Manisha","family":"Balwani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2019.01.020_bb0005","series-title":"The Metabolic and Molecurlar Bases of Inherited Disease","first-page":"2961","article-title":"Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias","author":"Anderson","year":"2001"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0010","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2008.08.003","article-title":"C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload","volume":"83","author":"Whatley","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0015","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10545-012-9544-4","article-title":"The incidence of inherited porphyrias in Europe","volume":"36","author":"Elder","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0020","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2133.2010.09631.x","article-title":"Molecular epidemiology of erythropoietic protoporphyria in the U.K","volume":"162","author":"Whatley","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2119\/molmed.2012.00340","volume":"19","author":"Balwani","year":"2013","journal-title":"Mol. Med."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0030","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MOH.0000000000000330","article-title":"Acute hepatic and erythropoietic porphyrias: from ALA synthases 1 and 2 to new molecular bases and treatments","volume":"24","author":"Manceau","year":"2017","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0035","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/ijd.1978.17.5.359","article-title":"Erythropoietic protoporphyria","volume":"17","author":"Poh-Fitzpatrick","year":"1978","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-4-19","article-title":"Erythropoietic protoporphyria","volume":"4","author":"Lecha","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0045","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0076-6879(00)19045-7","article-title":"Porphyrias: photosensitivity and phototherapy","volume":"319","author":"Poh-Fitzpatrick","year":"2000","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0050","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/hep.1840080235","article-title":"The liver in protoporphyria","volume":"8","author":"Bloomer","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0055","first-page":"323","article-title":"Hepatic protoporphyrin metabolism in patients with advanced protoporphyric liver disease","volume":"70","author":"Bloomer","year":"1997","journal-title":"The Yale journal of biology and medicine"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0060","unstructured":"Balwani, M., Bloomer, J., and Desnick, R. (2017). Erythropoietic Protoporphyria, Autosomal Recessive. In GeneReviews((R)), M.P. Adam, H.H. Ardinger, R.A. Pagon, S.E. Wallace, L.J.H. Bean, K. Stephens, and A. Amemiya, eds. (Seattle (WA)."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0065","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1182\/blood.V93.6.2105.406k28_2105_2110","article-title":"Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation","volume":"93","author":"Gouya","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng809","article-title":"The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH","volume":"30","author":"Gouya","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/498620","article-title":"Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria","volume":"78","author":"Gouya","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0080","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/humu.10212","article-title":"Human Gene Mutation Database (HGMD): 2003 update","volume":"21","author":"Stenson","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0085","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/bjd.14078","article-title":"Incomplete erythropoietic protoporphyria caused by a splice site modulator homozygous IVS3-48C polymorphism in the ferrochelatase gene","volume":"174","author":"Mizawa","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0090","unstructured":"Balwani, M., Bloomer, J., and Desnick, R. (1993). X-Linked Protoporphyria. In GeneReviews((R)), M.P. Adam, H.H. Ardinger, R.A. Pagon, S.E. Wallace, L.J.H. Bean, K. Stephens, and A. Amemiya, eds. (Seattle (WA)."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/cge.12562","article-title":"X-chromosomal inactivation directly influences the phenotypic manifestation of X-linked protoporphyria","volume":"89","author":"Brancaleoni","year":"2016","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamadermatol.2017.1557","article-title":"Clinical, Biochemical, and Genetic Characterization of north American patients with Erythropoietic Protoporphyria and X-linked Protoporphyria","volume":"153","author":"Balwani","year":"2017","journal-title":"JAMA dermatology"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0105","doi-asserted-by":"crossref","first-page":"E8045","DOI":"10.1073\/pnas.1700632114","article-title":"Mutation in human CLPX elevates levels of delta-aminolevulinate synthase and protoporphyrin IX to promote erythropoietic protoporphyria","volume":"114","author":"Yien","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0110","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00277-009-0859-7","article-title":"Acquired erythropoietic protoporphyria","volume":"89","author":"Blagojevic","year":"2010","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0115","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1046\/j.0022-202x.2001.01560.x","article-title":"Late-onset erythropoietic porphyria caused by a chromosome 18q deletion in erythroid cells","volume":"117","author":"Aplin","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0120","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/1346-8138.13709","article-title":"Case of late-onset erythropoietic protoporphyria with myelodysplastic syndrome who has homozygous IVS3-48C polymorphism in the ferrochelatase gene","volume":"44","author":"Suzuki","year":"2017","journal-title":"J. Dermatol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0125","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/jid.2012.467","article-title":"Late-onset X-linked dominant protoporphyria: an etiology of photosensitivity in the elderly","volume":"133","author":"Livideanu","year":"2013","journal-title":"The Journal of investigative dermatology"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0130","first-page":"561","article-title":"The diagnosis and management of erythropoietic protoporphyria","volume":"4","author":"Thapar","year":"2008","journal-title":"Gastroenterology & hepatology"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0190-9622(89)70187-0","article-title":"The \"priming phenomenon\" in the acute phototoxicity of erythropoietic protoporphyria","volume":"21","author":"Poh-Fitzpatrick","year":"1989","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0140","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1468-3083.2010.03640.x","article-title":"A homoallelic FECH mutation in a patient with both erythropoietic protoporphyria and palmar keratoderma","volume":"24","author":"Minder","year":"2010","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0145","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/bjd.14600","article-title":"Influence of meteorological data on sun tolerance in patients with erythropoietic protoporphyria in France","volume":"175","author":"de Bataille","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0150","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/gut.2006.097576","article-title":"Liver disease in erythropoietic protoporphyria: insights and implications for management","volume":"83","author":"Anstey","year":"2007","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0155","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/lt.20620","article-title":"Liver transplantation for erythropoietic protoporphyria liver disease","volume":"11","author":"McGuire","year":"2005","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0160","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.27086","article-title":"Liver transplantation in the management of porphyria","volume":"60","author":"Singal","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0165","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1365-2796.2010.02236.x","article-title":"Erythropoietic protoporphyria in Sweden: demographic, clinical, biochemical and genetic characteristics","volume":"269","author":"Wahlin","year":"2011","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0170","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1182\/blood-2007-04-088120","article-title":"Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria","volume":"110","author":"Holme","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0175","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood-2006-04-014142","article-title":"Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice","volume":"109","author":"Lyoumi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0180","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jaad.2006.11.030","article-title":"Symptomatic response of erythropoietic protoporphyria to iron supplementation","volume":"56","author":"Holme","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0185","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10545-017-0017-7","article-title":"Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity","volume":"40","author":"Barman-Aksoezen","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0190","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/eci.12503","article-title":"Homeostasis of iron and hepcidin in erythropoietic protoporphyria","volume":"45","author":"Bossi","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0195","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2133.2008.08616.x","article-title":"Serum 25-hydroxyvitamin D in erythropoietic protoporphyria","volume":"159","author":"Holme","year":"2008","journal-title":"Br. J. Dermatol."},{"issue":"Suppl. 3","key":"10.1016\/j.ymgme.2019.01.020_bb0200","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s10545-008-1037-0","article-title":"Vitamin D deficiency in patients with erythropoietic protoporphyria","volume":"33","author":"Spelt","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0205","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/bjd.15893","article-title":"Osteoporosis in patients with erythropoietic protoporphyria","volume":"177","author":"Biewenga","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0210","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1373\/clinchem.2015.245456","article-title":"Pitfalls in Erythrocyte Protoporphyrin Measurement for Diagnosis and monitoring of Protoporphyrias","volume":"61","author":"Gou","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0215","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2230.1993.tb00992.x","article-title":"Clinical utility of fluorometric scanning of plasma porphyrins for the diagnosis and typing of porphyrias","volume":"18","author":"Enriquez de Salamanca","year":"1993","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0220","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1086\/301870","article-title":"Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria","volume":"62","author":"Rufenacht","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0225","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1038\/sj.jid.5700924","article-title":"Gene dosage analysis identifies large deletions of the FECH gene in 10% of families with erythropoietic protoporphyria","volume":"127","author":"Whatley","year":"2007","journal-title":"The Journal of investigative dermatology"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0230","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1136\/jmg.2003.016121","article-title":"Autosomal recessive erythropoietic protoporphyria in the United Kingdom: prevalence and relationship to liver disease","volume":"41","author":"Whatley","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0235","first-page":"91","article-title":"A genotype-phenotype correlation between null-allele mutations in the ferrochelatase gene and liver complication in patients with erythropoietic protoporphyria","volume":"48","author":"Minder","year":"2002","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0240","first-page":"541","article-title":"Autosomal recessive erythropoietic protoporphyria: a syndrome of severe photosensitivity and liver failure","volume":"88","author":"Sarkany","year":"1995","journal-title":"QJM"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0245","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/1346-8138.14175","article-title":"Prevention of photosensitivity with action spectrum adjusted protection for erythropoietic protoporphyria","volume":"45","author":"Teramura","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0250","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bjd.12714","article-title":"Narrowband ultraviolet B phototherapy in erythropoietic protoporphyria: case series","volume":"170","author":"Sivaramakrishnan","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0255","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1046\/j.1365-2133.2000.03442.x","article-title":"Therapeutic options for erythropoietic protoporphyria","volume":"142","author":"Todd","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0260","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1365-2230.2002.01040.x","article-title":"Systemic photoprotection with alpha-tocopherol (vitamin E) and beta-carotene","volume":"27","author":"Anstey","year":"2002","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0265","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archderm.1977.01640090077011","article-title":"Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases","volume":"113","author":"Mathews-Roth","year":"1977","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0270","first-page":"84","article-title":"A systematic review of treatment options for dermal photosensitivity in erythropoietic protoporphyria","volume":"55","author":"Minder","year":"2009","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0275","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1001\/jamadermatol.2016.2303","article-title":"Novel Treatment using Cimetidine for Erythropoietic Protoporphyria in Children","volume":"152","author":"Tu","year":"2016","journal-title":"JAMA dermatology"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0280","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jamadermatol.2016.4049","article-title":"Insufficient evidence of cimetidine benefit in protoporphyria","volume":"153","author":"Langendonk","year":"2017","journal-title":"JAMA dermatology"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0285","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1517\/13543784.2010.535515","article-title":"Afamelanotide, an agonistic analog of alpha-melanocyte-stimulating hormone, in dermal phototoxicity of erythropoietic protoporphyria","volume":"19","author":"Minder","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0290","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMoa1411481","article-title":"Afamelanotide for Erythropoietic Protoporphyria","volume":"373","author":"Langendonk","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0295","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/bjd.13598","article-title":"Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria","volume":"172","author":"Biolcati","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0300","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/lt.22341","article-title":"Liver transplantation for erythropoietic protoporphyria in Europe. Liver transplantation : official publication of the American Association for the Study of","volume":"17","author":"Wahlin","year":"2011","journal-title":"Liver Diseases and the International Liver Transplantation Society"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0305","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-0781.1998.tb00011.x","article-title":"Hepatic complications of erythropoietic protoporphyria","volume":"14","author":"Gross","year":"1998","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0310","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/00007890-199903270-00023","article-title":"The value of intravenous heme-albumin and plasmapheresis in reducing postoperative complications of orthotopic liver transplantation for erythropoietic protoporphyria","volume":"67","author":"Reichheld","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0315","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1537-2995.2004.04190.x","article-title":"Red blood cell exchange transfusion in two patients with advanced erythropoietic protoporphyria","volume":"45","author":"Eichbaum","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0320","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/bmt.2009.132","article-title":"The role for BMT in erythropoietic protoporphyria","volume":"45","author":"Wahlin","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0325","doi-asserted-by":"crossref","first-page":"e1896","DOI":"10.1542\/peds.2006-0833","article-title":"Sequential liver and bone marrow transplantation for treatment of erythropoietic protoporphyria","volume":"118","author":"Rand","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2019.01.020_bb0330","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhep.2006.10.004","article-title":"Curative bone marrow transplantation in erythropoietic protoporphyria after reversal of severe cholestasis","volume":"46","author":"Wahlin","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0335","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/ajt.14581","article-title":"Erythropoietic protoporphyria in an adult with sequential liver and hematopoietic stem cell transplantation: a case report","volume":"18","author":"Windon","year":"2018","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0340","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bjh.13612","article-title":"X-linked protoporphyria: Iron supplementation improves protoporphyrin overload, liver damage and anaemia","volume":"173","author":"Landefeld","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgme.2019.01.020_bb0345","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/bjh.12485","article-title":"Clinical and biochemical improvement following low-dose intravenous iron therapy in a patient with erythropoietic protoporphyria","volume":"163","author":"Bentley","year":"2013","journal-title":"Br. J. Haematol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218306413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218306413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:27:37Z","timestamp":1761089257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719218306413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1096719218306413"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.01.020","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythropoietic Protoporphyria and X-Linked Protoporphyria: pathophysiology, genetics, clinical manifestations, and management","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}